UnknownNot Applicable

Mutation Detection for VRL

China40 participantsStarted 2021-11-10

Plain-language summary

Vitreoretinal lymphoma (VRL) is a rare but aggressive masquerade syndrome, which would be easily confused with uveitis. The diagnostic gold standard remains the pathologic examination of ocular specimen with invasiveness and low sensitivity. To improve the safety and accuracy of VRL diagnosis, alternative techniques using intraocular fluid (IOF) samples are emerging. In this study, we aimed to test the diagnostic value of mutation analysis for VRL

Who can participate

Age range18 Years – 70 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * suspected VRL patients who had intraocular fluid for mutation test. And got a clear diagnose of VRL or uveitis afther having dianostic tests and follow-up treatment Exclusion Criteria: * suspected VRL patients who lost in follow-up without a definitive diagnose, or whoever reluctance to participate our study

What they're measuring

the result of mutation test

Timeframe: at baseline, before treatment

Trial details

NCT IDNCT05102994

SponsorSun Yat-sen University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2022-04-01

View on ClinicalTrials.gov More Vitreoretinal Lymphoma trials